Cipla’s arm enters into commercial collaboration with BioQuiddity

01 Aug 2014 Evaluate

Cipla’s 100% subsidiary - Cipla Europe NV has entered into a commercial collaboration with BioQuiddity Inc., covering the territory of the European Union and certain other European countries, for BioQuiddity’s OneDose ReadyfusOR in regional anesthetic applications for post-surgical pain management.

Cipla intends to launch the CE Marked OneDose ReadyfusOR pre-filled with Ropivacaine under its own label into the German market late this year. The ready-to-use infusion systems are non-electric, ambulatory, and should enable seamless transition between sites of care.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company has emerged as one of the most respected pharmaceutical names in India as well as across more than 170 countries. 

Cipla Share Price

1498.65 -6.40 (-0.43%)
29-Dec-2025 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1723.60
Dr. Reddys Lab 1266.20
Cipla 1498.65
Zydus Lifesciences 903.65
Lupin 2095.90
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×